Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-25
DOI
10.3389/fimmu.2019.01402
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
- (2019) Xiaoyun Li et al. Nature Reviews Clinical Oncology
- Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumors
- (2019) Anna Schurich et al. Immunotherapy
- Glucose and Lipid Homeostasis and Inflammation in Humans Following an Isocaloric Ketogenic Diet
- (2019) Michael Rosenbaum et al. Obesity
- Ketogenic diet in cancer therapy
- (2018) Daniela D. Weber et al. Aging-US
- Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes
- (2018) Elizabeth F. Sutton et al. Cell Metabolism
- OUP accepted manuscript
- (2018) JOURNAL OF NUTRITION
- Anti-Diabetic Drugs: Cure or Risk Factors for Cancer?
- (2018) Jeny Laskar et al. PATHOLOGY & ONCOLOGY RESEARCH
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
- (2018) Jake S. O’Donnell et al. SEMINARS IN CANCER BIOLOGY
- Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells
- (2018) Qian Mu et al. OncoTargets and Therapy
- Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
- (2018) Muhammad Zubair Afzal et al. Journal for ImmunoTherapy of Cancer
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- Time-restricted feeding mitigates high-fat diet–enhanced mammary tumorigenesis in MMTV-PyMT mice
- (2018) S. Sundaram et al. NUTRITION RESEARCH
- The emerging role of ketogenic diets in cancer treatment
- (2018) Rainer Johannes Klement CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Is Resveratrol a Cancer Immunomodulatory Molecule?
- (2018) Ly Quoc Trung et al. Frontiers in Pharmacology
- Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
- (2017) Leisha A. Emens et al. EUROPEAN JOURNAL OF CANCER
- Naturally occurring immunomodulators with antitumor activity: An insight on their mechanisms of action
- (2017) Shimaa Ibrahim Abdelmonym Mohamed et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells
- (2017) Amy Lyons et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma
- (2017) Sun Hye Kim et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans
- (2017) J. Luis Espinoza et al. Oxidative Medicine and Cellular Longevity
- Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet
- (2016) Danielle M. Lussier et al. BMC CANCER
- Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
- (2016) Federico Pietrocola et al. CANCER CELL
- Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity
- (2016) Stefano Di Biase et al. CANCER CELL
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Obesity and tumor growth
- (2016) Christopher Wright et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
- (2016) C. Vernieri et al. Cancer Discovery
- Natural Polyphenols for Prevention and Treatment of Cancer
- (2016) Yue Zhou et al. Nutrients
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer
- (2016) R J Klement et al. Oncogenesis
- Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis
- (2016) Rainer J. Klement et al. PLoS One
- Effect of Intermittent versus Chronic Calorie Restriction on Tumor Incidence: A Systematic Review and Meta-Analysis of Animal Studies
- (2016) Yalan Chen et al. Scientific Reports
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan
- (2015) Sebastian Brandhorst et al. Cell Metabolism
- Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies
- (2015) Lang Wu et al. Scientific Reports
- Combinatorial Strategies for the Induction of Immunogenic Cell Death
- (2015) Lucillia Bezu et al. Frontiers in Immunology
- The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link
- (2015) Laura W. Bowers et al. Frontiers in Endocrinology
- Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model
- (2015) Raphael Johannes Morscher et al. PLoS One
- Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging
- (2014) Michelle Farazi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Roles of Caloric Restriction, Ketogenic Diet and Intermittent Fasting during Initiation, Progression and Metastasis of Cancer in Animal Models: A Systematic Review and Meta-Analysis
- (2014) Mengmeng Lv et al. PLoS One
- Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism
- (2014) Bryan G. Allen et al. Redox Biology
- Ketogenic Diets Enhance Oxidative Stress and Radio-Chemo-Therapy Responses in Lung Cancer Xenografts
- (2013) B. G. Allen et al. CLINICAL CANCER RESEARCH
- Selectively starving cancer cells through dietary manipulation: methods and clinical implications
- (2013) Brittany A Simone et al. Future Oncology
- Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors
- (2012) Liangshan Hu et al. CANCER BIOLOGY & THERAPY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Anti-inflammatory Effects of Resveratrol and Its Potential Use in Therapy of Immune-mediated Diseases
- (2012) Urban Švajger et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Resveratrol Prevents Endothelial Cells Injury in High-Dose Interleukin-2 Therapy against Melanoma
- (2012) Hongbing Guan et al. PLoS One
- The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model
- (2011) Brenda L. Soto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases--Safety, Pharmacokinetics, and Pharmacodynamics
- (2011) L. M. Howells et al. Cancer Prevention Research
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Effects of Intermittent and Chronic Calorie Restriction on Mammalian Target of Rapamycin (mTOR) and IGF-I Signaling Pathways in Mammary Fat Pad Tissues and Mammary Tumors
- (2011) Soner Dogan et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
- (2010) H.-H. S. Chow et al. Cancer Prevention Research
- Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index
- (2010) C. Lee et al. CANCER RESEARCH
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
- (2010) V. A. Brown et al. CANCER RESEARCH
- Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
- (2010) K. R. Patel et al. CANCER RESEARCH
- Calorie restriction and cancer prevention: metabolic and molecular mechanisms
- (2010) Valter D. Longo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Alternate-day fasting reduces global cell proliferation rates independently of dietary fat content in mice
- (2008) Krista A. Varady et al. NUTRITION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started